- Nasdaq: MTXX*
- Sector: Consumer
- Industry: Retail / Consumer
Acquired by Gryphon Investors.
Matrixx Initiatives has been engaged in the development and marketing of better ways to feel better through over-the-counter health care products that utilize innovative drug delivery systems for over 20 years. Matrixx Initiatives manufactures and markets Zicam® brand homeopathic and allopathic OTC products, including its clinically proven ZICAM® Cold Remedy Nasal Spray and Swab, ZICAM® Cold Remedy RAPIDMELTS®, ZICAM® Cold Remedy Oral Mist™, ZICAM® Cold Remedy Medicated Fruit Drops, ZICAM® Cold Remedy Ultra Crystals and ZICAM® Cold Remedy Lozenges. Matrixx products also include ZICAM® Cold Remedy Relief for Kids, ZICAM® Allergy Relief Spray and Swab, ZICAM® Extreme Congestion Relief and ZICAM®Intense Sinus Relief.
*past representation